Reid W Merryman

13PUBLICATIONS
99CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsiesImmunogenetics (incl. genetic immunology)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 25, 2026
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin.

|May 22, 2026
Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma.

|Apr 25, 2026
Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

|Jul 08, 2024
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.

Mazyar Shadman, Kwang W Ahn, Manmeet Kaur

|Apr 25, 2024
Advancements in the Management of Follicular Lymphoma: A Comprehensive Review

Reid Merryman, Özgür Mehtap, Ann LaCasce

Pageof 3

Frequent Collaborators

4 joint publications

Philippe Armand

3 joint publications

Ann S LaCasce

2 joint publications

Ajay Major

2 joint publications

Pallawi Torka